A Study in Healthy Volunteers and Patients with Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Trial Identifier: D5371C00001
Sponsor: AstraZeneca
NCTID:: NCT03766399
Start Date: November 2018
Primary Completion Date: June 2021
Study Completion Date: June 2021
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
English Translation

Trial Locations

Country Location
DE Berlin, DE, 14050
GB Harrow, GB, HA1 3UJ
GB Manchester, GB, M23 9GP
NZ Wellington, NZ, 6021